Goldman Sachs’ quarterly profit plunges on impact from fintech sale, real estate bets

France Nouvelles Nouvelles

Goldman Sachs’ quarterly profit plunges on impact from fintech sale, real estate bets
France Dernières Nouvelles,France Actualités
  • 📰 globeandmail
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 92%

Goldman Sachs reported net profit of $2.06-billion, or $5.47 per share, for the three months ended Sept. 30. That was lower than $3.07-billion, or $8.25 per share, a year ago

profit fell in the third quarter, weighed down by a writedown on its GreenSky fintech business and its investments in real estate.

CEO David Solomon has shifted the firm’s focus back to its traditional strengths – investment banking and trading, and aims to grow in asset and wealth management. GreenSky, which facilitates home improvement loans for consumers, was sold to a consortium of investment firms led by Sixth Street Partners.

Real estate investments were another drag on earnings as the bank booked an impairment charge of $358-million. That weighed on revenue from its asset and wealth management unit, which slipped 20 per cent to $3.23-billion.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

globeandmail /  🏆 5. in CA

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Hedge funds short food, beverage and tobacco stocks amid soaring bond yields -Goldman SachsHedge funds short food, beverage and tobacco stocks amid soaring bond yields -Goldman SachsMarket News
Lire la suite »

Goldman Sachs lifts Europe Inc's 2023 profit growth forecast to 3%Goldman Sachs lifts Europe Inc's 2023 profit growth forecast to 3%Explore stories from Atlantic Canada.
Lire la suite »

Obesity Drugs Are a Potential $100 Billion Opportunity by 2030, Goldman Sachs Analysts SayObesity Drugs Are a Potential $100 Billion Opportunity by 2030, Goldman Sachs Analysts SayAs the buzz surrounding weight-loss drugs gets ever louder, analysts at Goldman Sachs Group Inc. are predicting a potential $100 billion market opportunity, with Eli Lilly & Co. and Novo Nordisk A/S leading the pack.
Lire la suite »

Goldman Sachs profit plunges on impact from fintech sale, real estate betsGoldman Sachs profit plunges on impact from fintech sale, real estate betsThe Wall Street giant reported net profit of $2.06 billion, or $5.47 per share, for the three months ended Sept. 30, it said on Tuesday. Shares of the bank ...
Lire la suite »

Bank earnings: Could credit quality be this quarter's smoking gun?Bank earnings: Could credit quality be this quarter's smoking gun?Big Bank earnings kicked off last Friday, continuing into this week with Goldman Sachs (GS) and Bank of America (BAC) earnings on tap for Tuesday, October 17...
Lire la suite »

US futures slip as earnings floodgates open: Stock market news todayUS futures slip as earnings floodgates open: Stock market news todayAll eyes are on Goldman Sachs and Bank of America earnings for insight into the impact of high interest rates.
Lire la suite »



Render Time: 2025-03-03 01:49:45